ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: TH-PO579

Secondary Focal Segmental Glomerulosclerosis in Pregnancy: A Risk for Renal Transplant Patients

Session Information

  • Trainee Case Reports - II
    October 25, 2018 | Location: Exhibit Hall, San Diego Convention Center
    Abstract Time: 10:00 AM - 12:00 PM

Category: Trainee Case Reports

  • 1802 Transplantation: Clinical

Authors

  • Dines, Virginia, Mayo Clinic , Rochester, Minnesota, United States
  • D'Costa, Matthew R., Mayo Clinic , Rochester , Minnesota, United States
  • Kattah, Andrea G., Mayo Clinic , Rochester , Minnesota, United States
Introduction

Pre/eclampsia is usually the cause of worsening hypertension and proteinuria in pregnancy; however, these findings in a renal transplant patient lead to a wider differential. We present a case of focal segmental glomerulosclerosis (FSGS) in a pregnant patient 16 years post renal transplant.

Case Description

A 39 year old female with end stage renal disease secondary to lupus nephritis status/post living related kidney transplant, obesity, and hypertension presented with marked proteinuria and worsening hypertension at 14 weeks gestation. Her post-transplant course had been uncomplicated by proteinuria. At presentation, she developed worsening hypertension and 24h total protein was 3.2 g. With strict blood pressure control, urine albumin-to-creatinine ratio (ACR) decreased to 641 mg/g (figure). At 20 weeks, ACR increased to 4399 in the setting of worsening hypertension. She was admitted to the hospital, and urinalysis showed no hematuria and C3/C4, dsDNA and other serologic workup was negative. Kidney biopsy revealed cellular FSGS with glomerulomegaly and 70% foot process effacement, concerning for hyperfiltration injury vs de novo primary FSGS. Proteinuria initially improved with strict blood pressure control; however she developed worsening hypertension, proteinuria, and edema at 36 weeks gestation due to pre-eclampsia and underwent cesarean section. She continued to have nephrotic range proteinuria, and renal biopsy at 11 weeks post-partum demonstrated features of secondary FSGS.

Discussion

The differential for proteinuria and hypertension in pregnant renal transplant patients includes pre/eclampsia, rejection, transplant glomerulopathy, and recurrent or de novo glomerular disease. Pregnancy creates a physiologic state of hyperfiltration due to increased fluid retention and blood flow. While allografts generally adapt to these changes, patients with obesity and uncontrolled hypertension are at risk for hyperfiltration-induced renal injury and FSGS, which in this case, was unmasked by pregnancy.